GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Cash, Cash Equivalents, Marketable Securities

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Cash, Cash Equivalents, Marketable Securities : kr12.86 Mil (As of Feb. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Cash, Cash Equivalents, Marketable Securities?

Newbury Pharmaceuticals AB's quarterly cash, cash equivalents, marketable securities increased from Aug. 2024 (kr15.30 Mil) to Nov. 2024 (kr19.43 Mil) but then stayed the same from Nov. 2024 (kr19.43 Mil) to Feb. 2025 (kr12.86 Mil).

Newbury Pharmaceuticals AB's annual cash, cash equivalents, marketable securities declined from Aug. 2022 (kr33.33 Mil) to Aug. 2023 (kr8.53 Mil) but then increased from Aug. 2023 (kr8.53 Mil) to Aug. 2024 (kr15.30 Mil).


Newbury Pharmaceuticals AB Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Cash, Cash Equivalents, Marketable Securities Chart

Newbury Pharmaceuticals AB Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Cash, Cash Equivalents, Marketable Securities
13.15 33.33 8.53 15.30

Newbury Pharmaceuticals AB Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.41 15.43 15.30 19.43 12.86

Newbury Pharmaceuticals AB Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Newbury Pharmaceuticals AB  (OSTO:NEWBRY) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Newbury Pharmaceuticals AB Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Newbury Pharmaceuticals AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines